← Leaderboards
Brendan Tyler Finicle
University Of California-Irvine
$102,377
Attributed
$102,377
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $60.8K · FY2021–22$100K$75K$50K$25K$0
'21
'22
Funding mix
By agency
NIH$102,377 · 2
By mechanism
F99$83,932 · 1
F31$18,445 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California-Irvine
Same institution · by research overlap
- Melissa Bruckner Lodoen$4,521,583
- Rongsheng Jin$17,409,334
- Andrej Luptak$2,114,805
- Anand K Ganesan$12,565,599
- Michael Demetriou$19,395,048
Others in their field
Other Emerging Leaders on “Nuclease”
- Jacqueline K White · Jackson Laboratory$11,892,569
- Michael-Christopher Keogh · Epicypher, Inc.$9,158,528
- William H. Peranteau · Children'S Hosp Of Philadelphia$8,763,204
- Jeongmin Song · Cornell University$5,852,315
- Bryan J Venters · Epicypher, Inc.$5,487,083
- Samuel Henry Sternberg · Columbia University Health Sciences$4,355,500
Research focus
NucleasePublic HealthMissionNovel StrategiesOligonucleotidesProteinsIn VivoLifeNormal CellNormal Tissue MorphologyAntisense OligonucleotidesCancer TherapyAnticancer ResearchOncogenesInstitutionIn VitroBase PairingDrug ResistanceCommunitiesNeoplastic CellCytoplasmFellowshipCancer PatientRecycling
Grant awards (3)
Targeting intracellular trafficking for cancer therapy$41,574
F99 · FY2022 · CA · contact PI
Targeting intracellular trafficking for cancer therapy$42,358
F99 · FY2021 · CA · contact PI
Targeting endolysosomal trafficking to increase delivery of antisense oligonucleotides to tumors$18,445
F31 · FY2021 · CA · contact PI